Current Infectious Disease Reports

, Volume 3, Issue 3, pp 266–273 | Cite as

Nosocomial pneumonia: More than just ventilator-associated

  • Joseph R. Lentino
Article

Abstract

We reviewed literature published from 1995 through 2000 on developments in ventilator-associated pneumonia. There is no gold standard with which to compare the accuracy of various invasive procedures performed for diagnosis. Moreover, leaders in the field are calling for an outcomes-based analysis to assess the utility of invasive procedures. Two things are clear: 1) adequate empiric therapy is beneficial, and 2) changes in therapy based on recovery of pathogens by invasive means do not affect outcome. Clinicians are urged to review local antimicrobial resistance patterns and to initiate empiric therapy on the basis of those data.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    National Nosocomial Infections Surveillance Program.Monitoring hospital acquired infections to promote patient safety. United States 1990–1999. MMWR Morb Mortal Wkly Rep 2000, 49:149–153.Google Scholar
  2. 2.
    Heyland DK, Cook DJ, Griffith L, et al.: The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. Am J Respir Crit Care Med 1999, 159:1249–1256.PubMedGoogle Scholar
  3. 3.
    Ibrahim EH, Ward S, Sherman G, et al.: A comparative analysis of patients with early-onset vs. late-onset nosocomial pneumonia in the ICU setting. Chest 2000, 117:1434–1442.CrossRefGoogle Scholar
  4. 4.
    Violan JS, Fernandez JA, Benitez AB, et al.: Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med 2000, 28:2737–2741.CrossRefGoogle Scholar
  5. 5.
    Heyland DK, Cook DJ, Marshall J, et al.: The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Chest 1999, 115:1076–1084.The authors report that the greatest utility of bronchoscopic invasive testing is in helping clinicians confirm the presence or absence of nosocomial pneumonia. In patients found not to have pneumonia, antibiotic therapy could be promptly stopped.PubMedCrossRefGoogle Scholar
  6. 6.
    Fagon J-Y, Chastre J, Wolff M, et al.: Invasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med 2000, 132:621–630.These authors found that an invasive management strategy was associated with fewer deaths at 14 days, less organ dysfunction, and fewer days of antibiotics. Clinically managed patients were more likely to have microbial pathogens recovered from sputum and polymicrobial infections.Google Scholar
  7. 7.
    Grossman RF, Fein A: Evidence based assessment of diagnostic tests for ventilator-associated pneumonia. Chest 2000, 117(suppl):177S-181S.CrossRefGoogle Scholar
  8. 8.
    Flanagan PG: Diagnosis of ventilator-associated pneumonia. J Hosp Infect 1999, 41:887–899.This author provides a concise review of the utility of invasive sampling techniques, including potential problems with diagnostic reliability.CrossRefGoogle Scholar
  9. 9.
    Veber B, Souweine B, Gachot B, et al.: Comparison of direct examination of three types of bronchoscopy specimens used to diagnose nosocomial pneumonia. Crit Care Med 2000, 28:962–968.CrossRefGoogle Scholar
  10. 10.
    deJaeger A, Litalien C, Lacroix J, et al.: Protected specimen brush or broncho alveolar lavage to diagnose bacterial nosocomial pneumonia in ventilated adults: a meta-analysis. Crit Care Med 1999, 27:2548–2560.CrossRefGoogle Scholar
  11. 11.
    Torres A, El-Ebiary M: Bronchoscopic BAL in the diagnosis of ventilator-associated pneumonia. Chest 2000, 117(suppl):198S-202S.Google Scholar
  12. 12.
    Baughman RP: Protected-Specimen brush technique in the diagnosis of ventilator-associated pneumonia. Chest 2000, 117(suppl):203S-206S.CrossRefGoogle Scholar
  13. 13.
    Campbell GD: Blinded invasive diagnostic procedures in ventilator-associated pneumonia. Chest 2000, 117(suppl):207S-211S.CrossRefGoogle Scholar
  14. 14.
    American Thoracic Society: Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med 1996, 153:1711–1725.Google Scholar
  15. 15.
    Mandell LA, Campbell GD Jr: Nosocomial pneumonia guidelines. An international perspective. Chest 1998, 113(Suppl):188S-193S.PubMedCrossRefGoogle Scholar
  16. 16.
    Morehead RS, Pinto SJ: Ventilator-associated pneumonia. Arch Intern Med 2000, 160:1926–1936.CrossRefGoogle Scholar
  17. 17.
    Kollef M, Ward S: The influence of mini-BAL cultures on patient outcomes. Implications for the antibiotic management of ventilator-associated pneumonia. Chest 1998, 113:412–420.These authors report the most important determinant of outcome for patients with suspected VAP is antibiotic selection before obtaining results from lower airway sampling.PubMedCrossRefGoogle Scholar
  18. 18.
    Kollef M, Sherman G, Ward S, et al.: Inadequate antimicrobial treatment of infections. A risk factor for hospital mortality among critically ill patients. Chest 1999, 115:462–474.PubMedCrossRefGoogle Scholar
  19. 19.
    Allaouchiche B, Jaumain H, Chassard D, et al.: Gram stain of bronchoalveolar lavage fluid in the early diagnosis of ventilator-associated pneumonia. Br J Anaesth 1999, 83:845–849.PubMedGoogle Scholar
  20. 20.
    Mertens AH, Nagler JM, Galdermans DI, et al.: Quality assessment of protected specimen brush samples by microscopic cell count. Am J Respir Crit Care Med 1998, 157:1240–1243.PubMedGoogle Scholar
  21. 21.
    Niederman MS: Bronchoscopy in non-resolving nosocomial pneumonia. Chest 2000, 117(suppl):212S-218S.CrossRefGoogle Scholar
  22. 22.
    Niederman MS: Why can’t I see clearly now? I have a meta analysis. Crit Care Med 1999, 27:2596–2598.PubMedCrossRefGoogle Scholar
  23. 23.
    Smith TL, Pearson ML, Wilcox KR, et al.: Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999, 340:493–501.PubMedCrossRefGoogle Scholar
  24. 24.
    Sieradzki K, Roberts RB, Haber SW, et al.: The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999, 340:517–523.PubMedCrossRefGoogle Scholar
  25. 25.
    Hammer DH: Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 2000, 162:328–330.Google Scholar
  26. 26.
    Lentino JR, Rolsenkranz MA, Michael JA, et al.: Nosocomial aspergillosis: a retrospective review of airborne disease secondary to road construction and contaminated air conditioners. Am J Epidemiol 1982, 116:430–437.PubMedGoogle Scholar
  27. 27.
    Cook DJ, Walter SD, Cook RJ, et al.: Incidence of and risk factors for ventilator associated pneumonia in critically ill patients. Ann Intern Med 1998, 129:433–440.A large prospective study that identified risk factors for acquisition of VAP, some of which are potentially modifiable.PubMedGoogle Scholar
  28. 28.
    Steere AC, Mallison GF: Handwashing practices for the prevention of nosocomial infections. Ann Intern Med 1975, 83:683–690.PubMedGoogle Scholar
  29. 29.
    Patterson JE, Vecchio J, Pantelick EL, et al.: Association of contaminated gloves with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit. Am J Med 1991, 91:479–483.PubMedCrossRefGoogle Scholar
  30. 30.
    Ferrer M, Torres A, Gonzalez J, et al.: Utility of selective digestive decontamination in mechanically ventilated patients. Ann Intern Med 1994, 120:389–395.PubMedGoogle Scholar
  31. 31.
    Driks M, Craven DE, Celli BR, et al.: Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization. N Engl J Med 1987, 317:1376–1382.PubMedCrossRefGoogle Scholar
  32. 32.
    Prod’hom G, Leuenberger P, Koerfer J, et al.: Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med 1994, 120:653–662.PubMedGoogle Scholar
  33. 33.
    Cook DJ, Reeve BK, Guyatt GH, et al.: Stress ulcer prophylaxis in critically ill patients: resolving discordant meta-analyses. JAMA 1996, 275:308–314.PubMedCrossRefGoogle Scholar
  34. 34.
    Cook D, Guyatt G, Marshall J, et al.: A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998, 338:791–797.PubMedCrossRefGoogle Scholar
  35. 35.
    Kollef MH: The prevention of ventilator associated pneumonia. N Engl J Med 1999, 340:627–634.s is a concise and thoughtful evidence-based summary of the current literature on prevention of VAP.PubMedCrossRefGoogle Scholar
  36. 36.
    Glupczynski Y, Sibille Y: Nosocomial pneumonia: diagnosis, epidemiology and treatment. Acta Clinica Belgica 1999, 54:178–190.A succinct review of pathogens, risk factors, and therapy for nosocomial pneumonia.PubMedGoogle Scholar
  37. 37.
    Singh N, Yu VL: Rational empiric antibiotic prescription in the ICU. Clinical research is mandatory. Chest 2000, 117:1496–1499.CrossRefGoogle Scholar
  38. 38.
    Gruson D, Hilbert G, Vargas F, et al.: Rotation and restricted use of antibiotics in a medical intensive care unit. Am J Respir Crit Care Med 2000, 162:837–843.Google Scholar
  39. 39.
    Bressolle F, de la Coussaye J-E, Ayoub R, et al.: Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia. Pharmacokinetics and absolute bio-availability. Antimicrob Agents Chemother 1992, 36:1404–1411.PubMedGoogle Scholar
  40. 40.
    Muder RR: Pneumonia in residents of long term care facilities: epidemiology etiology, management, and prevention. Am J Med 1998, 105:319–330.PubMedCrossRefGoogle Scholar
  41. 41.
    Medina-Walpole AM, Katz PR: Nursing-home acquired pneumonia. J Am Geriatr Soc 1999, 47:1005–1015.PubMedGoogle Scholar
  42. 42.
    Sarkisian CA, Lachs MS: ``Failure to thrive’’ in older adults. Ann Intern Med 1996, 124:1072–1078.PubMedGoogle Scholar
  43. 43.
    Chan ED, Welsh CH: Geriatric respiratory medicine. Chest 1998, 114:1704–1733.PubMedCrossRefGoogle Scholar
  44. 44.
    Miller RA: The aging immune system: primer and prospectus. Science 1996, 23:70–74.CrossRefGoogle Scholar
  45. 45.
    Morley JE, Silver AJ: Nutritional issues in nursing home care. Ann Intern Med 1995, 123:850–859.PubMedGoogle Scholar
  46. 46.
    Mathur U, Bentley DW, Hall CB: Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill. Ann Intern Med 1980, 93:49–52.PubMedGoogle Scholar
  47. 47.
    Troy CJ, Peeling RW, Ellis AG, et al.: Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes. JAMA 1997, 277:1214–1218.PubMedCrossRefGoogle Scholar
  48. 48.
    Nuort JP, Butler JC, Crutcher JM, et al.: An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998, 338:1861–1868.CrossRefGoogle Scholar
  49. 49.
    Harkness GA, Benley DW, Roghmann KJ: Risk factors for nosocomial pneumonia in the elderly. Am J Med 1990, 89:457–461.PubMedCrossRefGoogle Scholar
  50. 50.
    Hanson LC, Weber DJ, Rutala WA, et al.: Risk factors for nosocomial pneumonia in the elderly. Am J Med 1992, 92:161–166.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2001

Authors and Affiliations

  • Joseph R. Lentino
    • 1
  1. 1.Section of Infectious DiseasesEdward Hines, Jr. Veterans Affairs HospitalHinesUSA

Personalised recommendations